Koral L - Search Results

1

Real-world outcomes of pazopanib in metastatic soft tissue sarcoma: a retrospective Turkish oncology group (TOG) study.

Bilici A, Koca S, Karaagac M, Aydin SG, Eraslan E, Kaplan MA, Ocak B, Goksu SS, Paydas S, Akgul F, Derin S, Ergun Y, Yekeduz E, Erol C, Ozyukseler DT, Demiray AG, Karaca M, Guc ZG, Menekse S, Cinkir HY, Gumusay O, Sakin A, Ozkul O, Demir H, Erdem D, Besiroglu M, Unal OU, Acar R, Koral L, Sahin S, Sakalar T, Bahceci A, Ozveren A, Gunaydin UM, Seker MM, Sunar V, Dal P, Artac M, Turhal S. Bilici A, et al. Among authors: koral l. J Cancer Res Clin Oncol. 2023 Sep;149(11):8243-8253. doi: 10.1007/s00432-023-04766-3. Epub 2023 Apr 17. J Cancer Res Clin Oncol. 2023. PMID: 37067546

2

The correlates of benefit from neoadjuvant chemotherapy before surgery in non-small-cell lung cancer: a metaregression analysis.

Bozcuk H, Abali H, Coskun S; Lung Cancer Committee of Turkish Oncology Group. Bozcuk H, et al. World J Surg Oncol. 2012 Aug 9;10(1):161. doi: 10.1186/1477-7819-10-161. World J Surg Oncol. 2012. PMID: 22877422 Free PMC article.

3

Complete response and long-term remission to anti-HER2 combined therapy in a patient with breast cancer presented with bone marrow metastases.

Artac M, Koral L, Toy H, Guler T, Boruban MC, Altundag K. Artac M, et al. Among authors: koral l. J Oncol Pharm Pract. 2014 Apr;20(2):141-5. doi: 10.1177/1078155213480201. Epub 2013 May 14. J Oncol Pharm Pract. 2014. PMID: 23676508

4

Clinical and pathologic features of patients with rare ovarian tumors: multi-center review of 167 patients by the anatolian society of medical oncology.

Bilici A, Inanc M, Ulas A, Akman T, Seker M, Babacan NA, Inal A, Bal O, Koral L, Sevinc A, Tufan G, Elkiran ET, Ustaalioglu BB, Yavuzsen T, Alkis N, Ozkan M, Gumus M. Bilici A, et al. Among authors: koral l. Asian Pac J Cancer Prev. 2014 Jan;14(11):6493-9. doi: 10.7314/apjcp.2013.14.11.6493. Asian Pac J Cancer Prev. 2014. PMID: 24377556 Free article.

5

Survival results and prognostic factors in T4 N0-3 non-small cell lung cancer patients according to the AJCC 7th edition staging system.

Arslan D, Bozcuk H, Gunduz S, Tural D, Tattli AM, Uysal M, Goksu SS, Bassorgun Cİ, Koral L, Coskun HS, Ozdogan M, Savas B. Arslan D, et al. Among authors: koral l. Asian Pac J Cancer Prev. 2014;15(6):2465-72. doi: 10.7314/apjcp.2014.15.6.2465. Asian Pac J Cancer Prev. 2014. PMID: 24761848 Free article.

6

Prognostic value of ERCC1, ERCC2, XRCC1, and TP53 single nucleotide polymorphisms in patients with early-stage non-small cell lung cancer.

Geredeli C, Artac M, Yildirim S, Inal A, Dede I, Guler T, Boruban MC, Koral L, Karaagac M, Zamani AG, Altinok T, Aribas O, Bozcuk H, Demirkazik A. Geredeli C, et al. Among authors: koral l. Tumour Biol. 2015 Jun;36(6):4279-85. doi: 10.1007/s13277-015-3066-2. Epub 2015 Jan 18. Tumour Biol. 2015. PMID: 25596702

7

Biatrial Cardiac Metastases in a Patient with Uterine Cervix Malignant Melanoma.

Geredeli C, Boruban MC, Poyraz N, Artac M, Aribas A, Koral L. Geredeli C, et al. Among authors: koral l. Case Rep Cardiol. 2015;2015:958756. doi: 10.1155/2015/958756. Epub 2015 Apr 28. Case Rep Cardiol. 2015. PMID: 26060585 Free PMC article.

8

Factors predicting lapatinib efficacy in HER-2+ metastatic breast carcinoma: Does it work better in different histologic subtypes?

Göksu SS, Bozcuk H, Koral L, Çakar B, Gündüz S, Tatlı AM, Arslan D, Uysal M, Koçer M, Artaç M, Karabulut B, Coşkun HS, Özdoğan M, Savaş B. Göksu SS, et al. Among authors: koral l. Indian J Cancer. 2015 Oct-Dec;52(4):517-9. doi: 10.4103/0019-509X.178382. Indian J Cancer. 2015. PMID: 26960462 Free article.

9

Perspective of Turkish Medicine Students on Cancer, Cancer Treatments, Palliative Care, and Oncologists (ARES Study): a Study of the Palliative Care Working Committee of the Turkish Oncology Group (TOG).

Oktay E, Levent M, Gelincik H, Aktaş G, Yumuk F, Koral L, Arpacı E, Keser M, Alkan A, Karci E, Karadurmuş N, Degirmencioglu S, Turan M, Uyeturk U, Cabuk D, Avci N, Toprak O, Ergen A, Urvay S, Bayman E, Petekkaya E, Nayir E, Paydaş S, Yavuzsen T, Senler FC, Yaren A, Barutca S, Şahinler İ, Ozyilkan O, Tanriverdi O. Oktay E, et al. Among authors: koral l. J Cancer Educ. 2020 Feb;35(1):69-75. doi: 10.1007/s13187-018-1441-6. J Cancer Educ. 2020. PMID: 30446981

10

Comparison of palonosetron and granisetron in triplet antiemetic therapy in nonmetastatic breast cancer patients receiving high emetogenic chemotherapy: a multicenter, prospective, and observational study.

Araz M, Karaagac M, Korkmaz L, Koral L, Inci F, Beypinar I, Uysal M, Artac M. Araz M, et al. Among authors: koral l. Cancer Chemother Pharmacol. 2019 Jun;83(6):1091-1097. doi: 10.1007/s00280-019-03831-4. Epub 2019 Apr 8. Cancer Chemother Pharmacol. 2019. PMID: 30963213

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

25 results

Search Page